| Operating Income | 127,250.41 | 164,691.21 | 125,613.36 | 126,479.26 |
| Total Income | 240,390.96 | 279,319.63 | 236,228.90 | 241,677.07 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Expenses | 6,033.74 | 8,879.26 | 5,826.66 | 7,510.40 |
| Selling & Administrative Expenses | 0.00 | -0.22 | 23.53 | 81.82 |
| Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Loss on Forex Transaction | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 219,754.04 | 256,680.36 | 215,874.80 | 222,974.81 |
| TOTAL OPERATING EXPENDITURE | 225,787.78 | 265,559.40 | 221,724.99 | 230,567.03 |
| Operating Profit Before Prov. & Cont. | 14,603.18 | 13,760.23 | 14,503.91 | 11,110.04 |
| Provisions & Write Offs | -579.10 | -554.19 | -338.64 | -423.50 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 |
| TOTAL EXPENDITURE | 225,208.68 | 265,005.21 | 221,386.35 | 230,143.53 |
| Tax | 1,690.25 | -9,106.01 | 1,884.33 | 1,480.15 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 13,492.03 | 23,420.43 | 12,958.22 | 10,053.39 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 13,492.03 | 23,420.43 | 12,958.22 | 10,053.39 |
| | | | | |
| EPS (Unit Curr.) | 10.67 | 37.03 | 20.49 | 15.89 |
| EPS (Adj) (Unit Curr.) | 10.67 | 18.52 | 10.25 | 7.95 |
| Calculated EPS (Unit Curr.) | 10.67 | 37.03 | 20.49 | 15.89 |
| Calculated EPS (Adj) (Unit Curr.) | 10.67 | 18.52 | 10.25 | 7.95 |
| Calculated EPS (Ann.) (Unit Curr.) | 42.66 | 148.11 | 81.95 | 63.58 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 42.66 | 74.06 | 40.98 | 31.79 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12,650.00 | 6,325.00 | 6,325.00 | 6,325.00 |
| Reserve & Surplus | 177,092.56 | 169,925.81 | 146,505.17 | 133,546.23 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
| PBIDTM(%) | 11.93 | 8.69 | 11.82 | 9.12 |
| PBDTM(%) | 11.93 | 8.69 | 11.82 | 9.12 |
| PATM(%) | 10.60 | 14.22 | 10.32 | 7.95 |
| | | | | |
| Net Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Loan Losses & Provision | 0.00 | 0.00 | 0.00 | 0.00 |
| Assets Under Management | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
| Return on Equity(%) | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses to Net Interest Income(%) | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost to Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Loan Loss Provision Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Loans Spreads(%) | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Interest Margin(%) | 0.00 | 0.00 | 0.00 | 0.00 |
| Provision Coverage Ratio(%) | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Adequacy Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Tier I Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Tier II Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
| Gross Non Performing Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Non Performing Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (%) Gross Non Performing Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (%) Net Non Performing Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Assets(Annualised) | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Loans Disbursed(Amt Rs cr) | 0.00 | 0.00 | 0.00 | 0.00 |
| Loans Sanctioned/Approved(Amt Rs cr) | 0.00 | 0.00 | 0.00 | 0.00 |
| Loan Book(Amt Rs cr) | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 |
| Diluted EPS | 10.67 | 37.03 | 20.49 | 15.89 |